• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因短期服用沃诺拉赞引起的低镁血症导致抽搐发作。

Convulsive Seizure Due to Hypomagnesemia Caused by Short-term Vonoprazan Intake.

机构信息

Department of Hematology, Hakodate Municipal Hospital, Japan.

出版信息

Intern Med. 2022 Jan 15;61(2):237-240. doi: 10.2169/internalmedicine.7758-21. Epub 2021 Jul 17.

DOI:10.2169/internalmedicine.7758-21
PMID:34275986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851186/
Abstract

A 71-year-old woman was admitted for the treatment of diffuse large B-cell lymphoma of the ileum. She had been taking lansoprazole but was switched to vonoprazan due to epigastric discomfort. Three weeks after starting vonoprazan intake, she had a convulsive seizure, and a blood test showed hypomagnesiemia. The cause of hypomagnesemia was considered to be malabsorption of magnesium from the intestinal tract associated with vonoprazan. After discontinuation of vonoprazan, the magnesium level quickly recovered, and the seizures did not relapse. It is important to consider the risk of hypomagnesemia in patients taking vonoprazan, even for a short period of time.

摘要

一位 71 岁女性因回肠弥漫性大 B 细胞淋巴瘤入院治疗。她一直在服用兰索拉唑,但由于上腹部不适,改用沃诺拉赞。开始服用沃诺拉赞 3 周后,她发生了抽搐性癫痫发作,血液检查显示低镁血症。低镁血症的原因被认为是与沃诺拉赞相关的肠道镁吸收不良。停用沃诺拉赞后,镁水平迅速恢复,癫痫未再发作。即使服用时间很短,也应考虑服用沃诺拉赞的患者发生低镁血症的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da6/8851186/ec7f01ae6556/1349-7235-61-0237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da6/8851186/ec7f01ae6556/1349-7235-61-0237-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7da6/8851186/ec7f01ae6556/1349-7235-61-0237-g001.jpg

相似文献

1
Convulsive Seizure Due to Hypomagnesemia Caused by Short-term Vonoprazan Intake.因短期服用沃诺拉赞引起的低镁血症导致抽搐发作。
Intern Med. 2022 Jan 15;61(2):237-240. doi: 10.2169/internalmedicine.7758-21. Epub 2021 Jul 17.
2
Severe Hypomagnesemia Associated with the Long-term Use of the Potassium-competitive Acid Blocker Vonoprazan.严重低镁血症与钾竞争性酸阻滞剂沃诺拉赞的长期使用相关。
Intern Med. 2022 Jan 1;61(1):119-122. doi: 10.2169/internalmedicine.7325-21. Epub 2021 Jun 26.
3
Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis.一项评估沃诺拉赞对比兰索拉唑在亚洲糜烂性食管炎患者中的疗效和安全性的 III 期、随机、双盲、多中心研究。
Gut. 2020 Feb;69(2):224-230. doi: 10.1136/gutjnl-2019-318365. Epub 2019 Aug 13.
4
Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study.Vonoprazan 预防低剂量阿司匹林相关溃疡复发:随机 3 期研究。
Gut. 2018 Jun;67(6):1033-1041. doi: 10.1136/gutjnl-2017-314852. Epub 2017 Dec 1.
5
Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.随机临床试验:沃克帕唑与兰索拉唑治疗胃或十二指肠溃疡患者的疗效和安全性——两项3期非劣效性随机对照试验的结果
Aliment Pharmacol Ther. 2017 Jan;45(2):240-252. doi: 10.1111/apt.13876. Epub 2016 Nov 27.
6
Randomised clinical trial: vonoprazan versus lansoprazole for the initial relief of heartburn in patients with erosive oesophagitis.随机临床试验:Vonoprazan 与兰索拉唑治疗糜烂性食管炎患者烧心的初始缓解。
Aliment Pharmacol Ther. 2019 Jan;49(2):140-146. doi: 10.1111/apt.15062.
7
Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis.随机临床试验:新型钾离子竞争性酸阻滞剂沃克沙唑与兰索拉唑治疗糜烂性食管炎的疗效比较
Aliment Pharmacol Ther. 2016 Jan;43(2):240-51. doi: 10.1111/apt.13461. Epub 2015 Nov 11.
8
Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study.Vonoprazan 预防 NSAID 长期治疗期间的溃疡复发:随机、兰索拉唑对照非劣效性和单盲扩展研究。
Gut. 2018 Jun;67(6):1042-1051. doi: 10.1136/gutjnl-2017-314010. Epub 2017 Oct 7.
9
Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole.愈合性糜烂性食管炎的维持治疗:沃诺拉赞与兰索拉唑的 III 期比较。
World J Gastroenterol. 2018 Apr 14;24(14):1550-1561. doi: 10.3748/wjg.v24.i14.1550.
10
Does the Novel Potassium-Competitive Acid Blocker Vonoprazan Cause More Hypergastrinemia than Conventional Proton Pump Inhibitors? A Multicenter Prospective Cross-Sectional Study.新型钾离子竞争性酸阻滞剂沃诺拉赞是否比传统质子泵抑制剂引起更多的高胃泌素血症?一项多中心前瞻性横断面研究。
Digestion. 2018;97(1):70-75. doi: 10.1159/000484217. Epub 2018 Feb 1.

引用本文的文献

1
Severe Hypomagnesemia in a Patient Treated Using Carboplatin Co-Administered with Vonoprazan.使用卡铂与沃克奥美拉唑联合治疗的患者出现严重低镁血症
Case Rep Oncol. 2025 Jan 3;18(1):151-158. doi: 10.1159/000542906. eCollection 2025 Jan-Dec.
2
The role of vonoprazan in patients with erosive esophagitis.沃克帕唑在糜烂性食管炎患者中的作用。
Therap Adv Gastroenterol. 2022 Sep 13;15:17562848221122623. doi: 10.1177/17562848221122623. eCollection 2022.

本文引用的文献

1
Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies.质子泵抑制剂与低镁血症:观察性研究的荟萃分析。
Medicine (Baltimore). 2019 Nov;98(44):e17788. doi: 10.1097/MD.0000000000017788.
2
Magnesium and Drugs.镁与药物。
Int J Mol Sci. 2019 Apr 28;20(9):2094. doi: 10.3390/ijms20092094.
3
Proton Pump Inhibitor-Associated Hypomagnesemia: A Retrospective Case-Control Study.质子泵抑制剂相关性低镁血症:一项回顾性病例对照研究。
Fed Pract. 2016 Dec;33(12):18-21.
4
Challenges in the Diagnosis of Magnesium Status.镁状态诊断中的挑战。
Nutrients. 2018 Sep 1;10(9):1202. doi: 10.3390/nu10091202.
5
Update on the Use of Vonoprazan: A Competitive Acid Blocker.沃克(伏诺拉生)的应用进展:一种竞争性抑酸剂
Gastroenterology. 2018 Feb;154(3):462-466. doi: 10.1053/j.gastro.2018.01.018. Epub 2018 Jan 11.
6
Intestinal Absorption and Factors Influencing Bioavailability of Magnesium-An Update.肠道对镁的吸收及影响其生物利用度的因素——最新进展
Curr Nutr Food Sci. 2017 Nov;13(4):260-278. doi: 10.2174/1573401313666170427162740.
7
Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms.质子泵抑制剂所致低镁血症:当前研究及提出的机制
World J Nephrol. 2016 Mar 6;5(2):152-7. doi: 10.5527/wjn.v5.i2.152.
8
Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects--a randomised open-label cross-over study.在健康成年男性受试者中,与埃索美拉唑 20mg 或雷贝拉唑 10mg 相比,沃诺拉赞 20mg 的抑酸作用——一项随机、开放标签交叉研究。
Aliment Pharmacol Ther. 2015 Sep;42(6):719-30. doi: 10.1111/apt.13325. Epub 2015 Jul 21.
9
Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study.质子泵抑制剂与普通人群低镁血症:基于人群的队列研究。
Am J Kidney Dis. 2015 Nov;66(5):775-82. doi: 10.1053/j.ajkd.2015.05.012. Epub 2015 Jun 26.
10
Copper and magnesium deficiencies in patients with short bowel syndrome receiving parenteral nutrition or oral feeding.接受肠外营养或口服喂养的短肠综合征患者的铜和镁缺乏症
Arq Gastroenterol. 2015 Apr-Jun;52(2):94-9. doi: 10.1590/S0004-28032015000200004.